Table 1.
Cancer types included in study with their corresponding sample sizes.
| Cancer type | Sample size |
|---|---|
| Adrenocortical carcinoma (ACC) | 89 |
| Bladder urothelial carcinoma (BLCA) | 129 |
| Breast invasive carcinoma (BRCA) | 964 |
| Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) | 192 |
| Cholangiocarcinoma (CHOL) | 35 |
| Colon adenocarcinoma (COAD) | 141 |
| Lymphoid neoplasm diffuse large B-cell lymphoma (DLBC) | 47 |
| Esophageal carcinoma (ESCA) | 185 |
| Glioblastoma multiforme (GBM) | 286 |
| Head and neck squamous cell carcinoma (HNSC) | 279 |
| Kidney chromophobe (KICH) | 65 |
| Kidney renal clear cell carcinoma (KIRC) | 417 |
| Kidney renal papillary cell carcinoma (KIRP) | 158 |
| Acute myeloid leukemia (LAML) | 173 |
| Brain lower grade glioma (LGG) | 280 |
| Liver hepatocellular carcinoma (LIHC) | 195 |
| Lung adenocarcinoma (LUAD) | 212 |
| Lung squamous cell carcinoma (LUSC) | 174 |
| Ovarian serous cystadenocarcinoma (OV) | 231 |
| Pancreatic adenocarcinoma (PAAD) | 149 |
| Rectum adenocarcinoma (READ) | 63 |
| Sarcoma (SARC) | 247 |
| Skin cutaneous melanoma (SKCM) | 336 |
| Stomach adenocarcinoma (STAD) | 267 |
| Uterine corpus endometrial carcinoma (UCEC) | 248 |
| Uterine carcinosarcoma (UCS) | 56 |
| Uveal melanoma (UVM) | 80 |